Progerin Expression in Alveolar Epithelial Cells Exacerbates Inflammatory Responses to SARS-CoV-2 Infection
In the authors' words
Age is a major determinant of severe coronavirus disease 2019 (COVID-19), yet the cell-intrinsic consequences of ageing for SARS-CoV-2 infection remain difficult to examine in human experimental systems. Induced pluripotent stem cell (iPSC)-derived tissues provide accessible models of infection but generally lack hallmarks of ageing. Here, we employed an iPSC line containing an inducible progerin cassette and differentiated these cells towards an alveolar type II-like epithelial fate. Progerin induction in differentiated cells increased DNA-damage-associated {gamma}H2AX staining and mitochondrial reactive oxygen species, reduced the heterochromatin-associated mark H3K9me3, and induced transcriptional programs associated with extracellular matrix remodeling, fibrosis and inflammation. Following infection with authentic SARS-CoV-2, progerin-expressing cultures exhibited a greater perturbation of the host transcriptome, including increased interferon-associated and inflammatory gene signatures. Transcriptomic analysis support higher viral RNA abundance in the aged model, and this was further confirmed by functional assays that showed increased infectious activity from condition media. Together, these data establish a temporally controlled model of selected ageing-associated phenotypes in human alveolar epithelial-like cells and suggest that progerin-induced cellular stress can amplify epithelial responses to SARS-CoV-2. More broadly, these findings distinguish epithelial-intrinsic inflammatory priming from the multicellular pathology of severe COVID-19.
Appeared: Wednesday, November 18. bioRxiv. Preprint, not yet peer-reviewed.